Brain-derived neurotrophic factor and airway fibrosis in asthma

Michelle R. Freeman, Venkatachalem Sathish, Logan Manlove, Shengyu Wang, Rodney Jr. Britt, Michael A. Thompson, Christina M Pabelick, Y.s. Prakash

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Airway remodeling in asthma driven by inflammation involves proliferation of epithelial cells and airway smooth muscle (ASM), as well as enhanced extracellular matrix (ECM) generation and deposition, i.e., fibrosis. Accordingly, understanding profibrotic mechanisms is important for developing novel therapeutic strategies in asthma. Recent studies, including our own, have suggested a role for locally produced growth factors such as brain-derived neurotrophic factor (BDNF) in mediating and modulating inflammation effects. In this study, we explored the profibrotic influence of BDNF in the context of asthma by examining expression, activity, and deposition of ECM proteins in primary ASM cells isolated from asthmatic vs. nonasthmatic patients. Basal BDNF expression and secretion, and levels of the high-affinity BDNF receptor TrkB, were higher in asthmatic ASM. Exogenous BDNF significantly increased ECM production and deposition, especially of collagen-1 and collagen-3 (less so fibronectin) and the activity of matrix metalloproteinases (MMP-2, MMP-9). Exposure to the proinflammatory cytokine TNFα significantly increased BDNF secretion, particularly in asthmatic ASM, whereas no significant changes were observed with IL-13. Chelation of BDNF using TrkB-Fc reversed TNFα-induced increase in ECM deposition. Conditioned media from asthmatic ASM enhanced ECM generation in nonasthmatic ASM, which was blunted by BDNF chelation. Inflammation-induced changes in MMP-2, MMP-9, and tissue inhibitor metalloproteinases (TIMP-1, TIMP-2) were reversed in the presence of TrkB-Fc. These novel data suggest ASM as an inflammation-sensitive source of BDNF within human airways, with autocrine effects on fibrosis relevant to asthma.

Original languageEnglish (US)
Pages (from-to)L360-L370
JournalAmerican Journal of Physiology - Lung Cellular and Molecular Physiology
Volume313
Issue number2
DOIs
StatePublished - 2017

Fingerprint

Brain-Derived Neurotrophic Factor
Fibrosis
Asthma
Smooth Muscle
Matrix Metalloproteinases
Extracellular Matrix
Inflammation
Tissue Inhibitor of Metalloproteinase-1
Collagen
trkB Receptor
Airway Remodeling
Tissue Inhibitor of Metalloproteinase-2
Interleukin-13
Extracellular Matrix Proteins
Matrix Metalloproteinase 2
Conditioned Culture Medium
Fibronectins
Smooth Muscle Myocytes
Intercellular Signaling Peptides and Proteins
Epithelial Cells

Keywords

  • Airway smooth muscle
  • Collagen
  • Extracellular matrix
  • Neurotrophin
  • Tropomyosin-related kinase

ASJC Scopus subject areas

  • Physiology
  • Pulmonary and Respiratory Medicine
  • Cell Biology
  • Physiology (medical)

Cite this

Brain-derived neurotrophic factor and airway fibrosis in asthma. / Freeman, Michelle R.; Sathish, Venkatachalem; Manlove, Logan; Wang, Shengyu; Britt, Rodney Jr.; Thompson, Michael A.; Pabelick, Christina M; Prakash, Y.s.

In: American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 313, No. 2, 2017, p. L360-L370.

Research output: Contribution to journalArticle

Freeman, Michelle R. ; Sathish, Venkatachalem ; Manlove, Logan ; Wang, Shengyu ; Britt, Rodney Jr. ; Thompson, Michael A. ; Pabelick, Christina M ; Prakash, Y.s. / Brain-derived neurotrophic factor and airway fibrosis in asthma. In: American Journal of Physiology - Lung Cellular and Molecular Physiology. 2017 ; Vol. 313, No. 2. pp. L360-L370.
@article{6edd8297631b4527840b243b56121a38,
title = "Brain-derived neurotrophic factor and airway fibrosis in asthma",
abstract = "Airway remodeling in asthma driven by inflammation involves proliferation of epithelial cells and airway smooth muscle (ASM), as well as enhanced extracellular matrix (ECM) generation and deposition, i.e., fibrosis. Accordingly, understanding profibrotic mechanisms is important for developing novel therapeutic strategies in asthma. Recent studies, including our own, have suggested a role for locally produced growth factors such as brain-derived neurotrophic factor (BDNF) in mediating and modulating inflammation effects. In this study, we explored the profibrotic influence of BDNF in the context of asthma by examining expression, activity, and deposition of ECM proteins in primary ASM cells isolated from asthmatic vs. nonasthmatic patients. Basal BDNF expression and secretion, and levels of the high-affinity BDNF receptor TrkB, were higher in asthmatic ASM. Exogenous BDNF significantly increased ECM production and deposition, especially of collagen-1 and collagen-3 (less so fibronectin) and the activity of matrix metalloproteinases (MMP-2, MMP-9). Exposure to the proinflammatory cytokine TNFα significantly increased BDNF secretion, particularly in asthmatic ASM, whereas no significant changes were observed with IL-13. Chelation of BDNF using TrkB-Fc reversed TNFα-induced increase in ECM deposition. Conditioned media from asthmatic ASM enhanced ECM generation in nonasthmatic ASM, which was blunted by BDNF chelation. Inflammation-induced changes in MMP-2, MMP-9, and tissue inhibitor metalloproteinases (TIMP-1, TIMP-2) were reversed in the presence of TrkB-Fc. These novel data suggest ASM as an inflammation-sensitive source of BDNF within human airways, with autocrine effects on fibrosis relevant to asthma.",
keywords = "Airway smooth muscle, Collagen, Extracellular matrix, Neurotrophin, Tropomyosin-related kinase",
author = "Freeman, {Michelle R.} and Venkatachalem Sathish and Logan Manlove and Shengyu Wang and Britt, {Rodney Jr.} and Thompson, {Michael A.} and Pabelick, {Christina M} and Y.s. Prakash",
year = "2017",
doi = "10.1152/ajplung.00580.2016",
language = "English (US)",
volume = "313",
pages = "L360--L370",
journal = "American Journal of Physiology",
issn = "1040-0605",
publisher = "American Physiological Society",
number = "2",

}

TY - JOUR

T1 - Brain-derived neurotrophic factor and airway fibrosis in asthma

AU - Freeman, Michelle R.

AU - Sathish, Venkatachalem

AU - Manlove, Logan

AU - Wang, Shengyu

AU - Britt, Rodney Jr.

AU - Thompson, Michael A.

AU - Pabelick, Christina M

AU - Prakash, Y.s.

PY - 2017

Y1 - 2017

N2 - Airway remodeling in asthma driven by inflammation involves proliferation of epithelial cells and airway smooth muscle (ASM), as well as enhanced extracellular matrix (ECM) generation and deposition, i.e., fibrosis. Accordingly, understanding profibrotic mechanisms is important for developing novel therapeutic strategies in asthma. Recent studies, including our own, have suggested a role for locally produced growth factors such as brain-derived neurotrophic factor (BDNF) in mediating and modulating inflammation effects. In this study, we explored the profibrotic influence of BDNF in the context of asthma by examining expression, activity, and deposition of ECM proteins in primary ASM cells isolated from asthmatic vs. nonasthmatic patients. Basal BDNF expression and secretion, and levels of the high-affinity BDNF receptor TrkB, were higher in asthmatic ASM. Exogenous BDNF significantly increased ECM production and deposition, especially of collagen-1 and collagen-3 (less so fibronectin) and the activity of matrix metalloproteinases (MMP-2, MMP-9). Exposure to the proinflammatory cytokine TNFα significantly increased BDNF secretion, particularly in asthmatic ASM, whereas no significant changes were observed with IL-13. Chelation of BDNF using TrkB-Fc reversed TNFα-induced increase in ECM deposition. Conditioned media from asthmatic ASM enhanced ECM generation in nonasthmatic ASM, which was blunted by BDNF chelation. Inflammation-induced changes in MMP-2, MMP-9, and tissue inhibitor metalloproteinases (TIMP-1, TIMP-2) were reversed in the presence of TrkB-Fc. These novel data suggest ASM as an inflammation-sensitive source of BDNF within human airways, with autocrine effects on fibrosis relevant to asthma.

AB - Airway remodeling in asthma driven by inflammation involves proliferation of epithelial cells and airway smooth muscle (ASM), as well as enhanced extracellular matrix (ECM) generation and deposition, i.e., fibrosis. Accordingly, understanding profibrotic mechanisms is important for developing novel therapeutic strategies in asthma. Recent studies, including our own, have suggested a role for locally produced growth factors such as brain-derived neurotrophic factor (BDNF) in mediating and modulating inflammation effects. In this study, we explored the profibrotic influence of BDNF in the context of asthma by examining expression, activity, and deposition of ECM proteins in primary ASM cells isolated from asthmatic vs. nonasthmatic patients. Basal BDNF expression and secretion, and levels of the high-affinity BDNF receptor TrkB, were higher in asthmatic ASM. Exogenous BDNF significantly increased ECM production and deposition, especially of collagen-1 and collagen-3 (less so fibronectin) and the activity of matrix metalloproteinases (MMP-2, MMP-9). Exposure to the proinflammatory cytokine TNFα significantly increased BDNF secretion, particularly in asthmatic ASM, whereas no significant changes were observed with IL-13. Chelation of BDNF using TrkB-Fc reversed TNFα-induced increase in ECM deposition. Conditioned media from asthmatic ASM enhanced ECM generation in nonasthmatic ASM, which was blunted by BDNF chelation. Inflammation-induced changes in MMP-2, MMP-9, and tissue inhibitor metalloproteinases (TIMP-1, TIMP-2) were reversed in the presence of TrkB-Fc. These novel data suggest ASM as an inflammation-sensitive source of BDNF within human airways, with autocrine effects on fibrosis relevant to asthma.

KW - Airway smooth muscle

KW - Collagen

KW - Extracellular matrix

KW - Neurotrophin

KW - Tropomyosin-related kinase

UR - http://www.scopus.com/inward/record.url?scp=85026755851&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026755851&partnerID=8YFLogxK

U2 - 10.1152/ajplung.00580.2016

DO - 10.1152/ajplung.00580.2016

M3 - Article

C2 - 28522569

AN - SCOPUS:85026755851

VL - 313

SP - L360-L370

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 1040-0605

IS - 2

ER -